BlackRock

BlackRock’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

BlackRock’s Portfolio EUCRW Stock Details EUCRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-251,162	Closed	-$6K	–	5887
2022 Q3	$6K	Sell	251,162 -46,843	-16%	-$2.96K	﹤0.01%	5628
2022 Q2	$9K	Sell	298,005 -2,039	-0.7%	-$328	﹤0.01%	5643
2022 Q1	$56K	Hold	300,044	–	–	﹤0.01%	5403
2021 Q4	$173K	Sell	300,044 -8,289	-3%	-$6.1K	﹤0.01%	5138
2021 Q3	$221K	Hold	308,333	–	–	﹤0.01%	4962
2021 Q2	$321K	Buy	308,333 +2	+0%	+$2	﹤0.01%	4793
2021 Q1	$386K	Buy	+308,331	New	+$500K	﹤0.01%	4647

Other funds holding EUCRW

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Altium Capital Management New York $42M AUM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Arena Investors Purchase, New York $5.88M AUM 0.27% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return